End-of-day quote
Shenzhen S.E.
23:00:00 14/05/2024 BST
|
5-day change
|
1st Jan Change
|
4.02
CNY
|
+1.52%
|
|
-3.60%
|
-37.38%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,730
|
3,905
|
2,662
|
2,748
|
3,317
|
3,929
|
Enterprise Value (EV)
1 |
2,353
|
3,556
|
2,421
|
2,349
|
3,023
|
3,684
|
P/E ratio
|
-10.3
x
|
42.8
x
|
202
x
|
153
x
|
112
x
|
747
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
0.16%
|
Capitalization / Revenue
|
6.07
x
|
9.37
x
|
5.95
x
|
4.18
x
|
5.6
x
|
10.1
x
|
EV / Revenue
|
5.23
x
|
8.53
x
|
5.41
x
|
3.57
x
|
5.1
x
|
9.51
x
|
EV / EBITDA
|
565
x
|
192
x
|
37.1
x
|
44.2
x
|
52.2
x
|
925
x
|
EV / FCF
|
863
x
|
1,681
x
|
-51.4
x
|
-69.4
x
|
-51.7
x
|
203
x
|
FCF Yield
|
0.12%
|
0.06%
|
-1.95%
|
-1.44%
|
-1.94%
|
0.49%
|
Price to Book
|
3.8
x
|
4.83
x
|
3.24
x
|
3.27
x
|
3.81
x
|
4.48
x
|
Nbr of stocks (in thousands)
|
612,000
|
612,000
|
612,000
|
612,000
|
612,000
|
612,000
|
Reference price
2 |
4.460
|
6.380
|
4.350
|
4.490
|
5.420
|
6.420
|
Announcement Date
|
18/04/19
|
23/04/20
|
21/04/21
|
19/04/22
|
19/04/23
|
28/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
449.9
|
416.9
|
447.3
|
657.2
|
592.3
|
387.3
|
EBITDA
1 |
4.166
|
18.49
|
65.3
|
53.19
|
57.91
|
3.981
|
EBIT
1 |
-46.49
|
-26.22
|
24.69
|
19.68
|
24.82
|
-18.81
|
Operating Margin
|
-10.33%
|
-6.29%
|
5.52%
|
2.99%
|
4.19%
|
-4.86%
|
Earnings before Tax (EBT)
1 |
-273.4
|
92.39
|
17.05
|
17.7
|
31.08
|
10.64
|
Net income
1 |
-264.1
|
91.25
|
13.18
|
17.95
|
29.63
|
5.233
|
Net margin
|
-58.7%
|
21.89%
|
2.95%
|
2.73%
|
5%
|
1.35%
|
EPS
2 |
-0.4315
|
0.1491
|
0.0215
|
0.0293
|
0.0484
|
0.008600
|
Free Cash Flow
1 |
2.727
|
2.115
|
-47.14
|
-33.86
|
-58.51
|
18.15
|
FCF margin
|
0.61%
|
0.51%
|
-10.54%
|
-5.15%
|
-9.88%
|
4.69%
|
FCF Conversion (EBITDA)
|
65.46%
|
11.44%
|
-
|
-
|
-
|
455.92%
|
FCF Conversion (Net income)
|
-
|
2.32%
|
-
|
-
|
-
|
346.82%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
0.0100
|
Announcement Date
|
18/04/19
|
23/04/20
|
21/04/21
|
19/04/22
|
19/04/23
|
28/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
377
|
349
|
241
|
399
|
294
|
245
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.73
|
2.11
|
-47.1
|
-33.9
|
-58.5
|
18.2
|
ROE (net income / shareholders' equity)
|
-31%
|
12%
|
1.62%
|
2.16%
|
3.47%
|
0.6%
|
ROA (Net income/ Total Assets)
|
-2.5%
|
-1.62%
|
1.56%
|
1.23%
|
1.53%
|
-1.17%
|
Assets
1 |
10,582
|
-5,620
|
843.9
|
1,461
|
1,941
|
-446.1
|
Book Value Per Share
2 |
1.170
|
1.320
|
1.340
|
1.370
|
1.420
|
1.430
|
Cash Flow per Share
2 |
0.7200
|
0.6800
|
0.5900
|
0.6600
|
0.5000
|
0.4400
|
Capex
1 |
31.6
|
10.4
|
17.7
|
19.2
|
15
|
6.97
|
Capex / Sales
|
7.03%
|
2.48%
|
3.95%
|
2.93%
|
2.53%
|
1.8%
|
Announcement Date
|
18/04/19
|
23/04/20
|
21/04/21
|
19/04/22
|
19/04/23
|
28/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -37.38% | 335M | | +17.44% | 66.22B | | +3.54% | 49.24B | | +18.03% | 41.4B | | +21.48% | 26.62B | | +13.22% | 19.84B | | +2.07% | 17.44B | | -11.70% | 15.92B | | -23.54% | 15.57B | | +2.57% | 15.45B |
Other Specialty Chemicals
|